SPDR S&P Pharmaceuticals ETF
XPH
XPH
78 hedge funds and large institutions have $107M invested in SPDR S&P Pharmaceuticals ETF in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 23 increasing their positions, 17 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 78 → 78 (0)
48% less call options, than puts
Call options by funds: $452K | Put options by funds: $872K
Holders
78
Holding in Top 10
–
Calls
$452K
Puts
$872K
Top Buyers
| 1 | +$6.2M | |
| 2 | +$2.63M | |
| 3 | +$2.43M | |
| 4 |
FIM
FWL Investment Management
Dallas,
Texas
|
+$1.68M |
| 5 |
TAM
Tocqueville Asset Management
New York
|
+$1.59M |
Top Sellers
| 1 | -$4.61M | |
| 2 | -$2.27M | |
| 3 | -$1.6M | |
| 4 |
IMC Chicago
Chicago,
Illinois
|
-$527K |
| 5 |
FTUS
Flow Traders U.S.
New York
|
-$378K |